0001538550-16-000002.txt : 20160406 0001538550-16-000002.hdr.sgml : 20160406 20160406151603 ACCESSION NUMBER: 0001538550-16-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160406 DATE AS OF CHANGE: 20160406 EFFECTIVENESS DATE: 20160406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ImmuneXcite, Inc. CENTRAL INDEX KEY: 0001538550 IRS NUMBER: 260301680 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-252821 FILM NUMBER: 161557407 BUSINESS ADDRESS: STREET 1: 64 GROVE STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-658-7940 MAIL ADDRESS: STREET 1: 64 GROVE STREET CITY: WATERTOWN STATE: MA ZIP: 02472 D/A 1 primary_doc.xml X0707 D/A LIVE 0001538550 ImmuneXcite, Inc. 3 Forbes Road Lexington MA MASSACHUSETTS 02421 781-674-4300 DELAWARE None None Corporation true David Schechter c/o ImmuneXcite, Inc. 3 Forbes Road Lexington MA MASSACHUSETTS 02421 Director Eric Rowinsky c/o ImmuneXcite, Inc. 3 Forbes Road Lexington MA MASSACHUSETTS 02421 Director Eric Furfine c/o ImmuneXcite, Inc. 3 Forbes Road Lexington MA MASSACHUSETTS 02421 Executive Officer Director James Geraghty c/o ImmuneXcite, Inc. 3 Forbes Road Lexington MA MASSACHUSETTS 02421 Director John Edwards c/o ImmuneXcite, Inc. 3 Forbes Road Lexington MA MASSACHUSETTS 02421 Executive Officer Director Biotechnology Decline to Disclose 06b true 0001538550-15-000001 2015-11-25 true true false 0 8631882 6967501 1664381 Total Amount Sold includes conversion of outstanding convertible promissory notes. false 72 0 0 360000 true false ImmuneXcite, Inc. /s/ Eric S. Furfine Eric S. Furfine, Ph.D. CSO and Acting CEO 2016-04-06